News and Insights

Stay up to date with AVBCC’s latest news and insights.

AVBCC Recognizes Iovance Biotherapeutics’ Dr. Fred Vogt with Inaugural Global Cancer Research & Innovation Award

Issues and Challenges with the Effectuation of Maximum Fair Prices for Medicare Part B Drugs

Cell Therapy Commercialization Symposium White Papers

AVBCC SoCal Regional White Paper

graphic with the number 40 inside a circle

40 Under 40 In Cancer

Celebrating Rising Leaders and Lifetime Mavericks: The 2026 40 Under 40 in Cancer Celebration

How to optimize account activation in the evolving US oncology ecosystem

nicolas ferreyros smiles for a portrait.

AVBCC Co-Chairs

Meet Nicolas Ferreyros, Co-Chair of the 2025 AVBCC Educational Summit & Program

AVBCC Proudly Supports the 2025 Conquer Cancer Young Investigator Award Recipient: Dr. Lorena Caulkins

stephen speicher, m.d., m.s. smiles in a circular portrait.

AVBCC Co-Chairs

Meet Stephen Speicher, M.D., M.S., one of the Educational Summit & Program Chairs AVBCC2025

Advancing Value-Based Cancer Care: The Mission and Community Behind AVBCC

Meet the 2025 AVBCC Co-Chairs

Meet the AVBCC Team!

Upcoming Conferences

AVBCC Recognizes Iovance Biotherapeutics’ Dr. Fred Vogt with Inaugural Global Cancer Research & Innovation Award

New York, NY – The Association for Value-Based Cancer Care (AVBCC) is pleased to announce Fred Vogt, PhD, JD, Interim…

Issues and Challenges with the Effectuation of Maximum Fair Prices for Medicare Part B Drugs

Under the authority provided in the Inflation Reduction Act (IRA) of 2022, Medicare can now negotiate prices with drug manufacturers…

Cell Therapy Commercialization Symposium White Papers

Nine years after the first CAR T-cell therapy was launched, we’re still experiencing barriers that affect the commercialization of cell…

AVBCC SoCal Regional White Paper

On Friday, June 26, 2026, AVBCC tried something we had never tried: we supplemented the big conversations with commitments. After…